Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

NAAS RATING: 5.23, Impact Factor: RJIF 5.98 | Free Publication Certificate
updates
NAAS Rating: 5.23 new
Vol. 10, Issue 7 (2021)

De novo transcriptome analysis of a medicinal plant: Telosma pallida L.

Author(s):
Umaretiya Vidisha R, Dr. DR Mehta and Hirani Nimisha V
Abstract:
Telosma pallida L. is a member of the Asclepiadaceae family of plants with 2n=22. It is been said to neutralise Tridosha in the past. Next-generation sequencing was carried out in an oxford nanopore sequencer and 571,448, 307,608, 1,320,760, 14,597, and 43,006 sequences were generated in the root, stem, leaf, flower, and fruit, respectively. After de novo assembly, N50 measurements of contigs from CLC, CAP3, and CD-HIT were found to be 1557 bp, 1769 bp, and 1827 bp, respectively. The top hit species distribution was against the species Coffea arabica, according to a similarity search. Differential gene expression revealed that enzymes involved in the biosynthesis of monoterpenoid indole alkaloids were more prevalent in the stem and leaf than in the root, flower and fruit. It is the first-ever information about this plant and it will help with pharmacological studies of Telosma pallida L.
Pages: 31-35  |  51 Views  4 Downloads
How to cite this article:
Umaretiya Vidisha R, Dr. DR Mehta, Hirani Nimisha V. De novo transcriptome analysis of a medicinal plant: Telosma pallida L.. Pharma Innovation 2021;10(7):31-35.
The Pharma Innovation Journal